InvestorsHub Logo
Followers 218
Posts 9811
Boards Moderated 1
Alias Born 10/20/2008

Re: None

Sunday, 03/04/2012 7:18:50 AM

Sunday, March 04, 2012 7:18:50 AM

Post# of 4887
Case Study 3:

An acquisition of a generic pharmaceutical company by a rival resulted in an order that required the divestiture of 3 products to a third party acquirer.

The responsibility of Groupe Athena was to act as the overseer for the divestiture to review: (1) the transfer of product, technology and marketing information, (2) the implementation of the technology by the acquiring company and (3) the subsequent verification that the client did not have access to the Confidential Business Information.